Optimization and application of silver staining of non-glycosylated and glycosylated proteins and nucleic acids for agarose native gel electrophoresis

Int J Biol Macromol. 2021 Oct 31:189:869-878. doi: 10.1016/j.ijbiomac.2021.08.142. Epub 2021 Aug 23.

Abstract

Electrophoresis is one of the major techniques to analyze macromolecular structure and interaction. Its capability depends on the sensitivity and specificity of the staining methods. We have here examined silver staining of proteins and nucleic acids separated by agarose native gel electrophoresis. By comparing five commercial kits, we identified Silver Stain Plus from Bio-Rad most adequate, as it provided little background staining and reasonable band staining. One of the disadvantages of the Silver Stain Plus kit is its variable staining of glycoproteins as tested with several model samples, including hen egg white proteins, α1-acid glycoprotein and SARS-CoV-2 Spike protein. One of the advantages of silver staining is its ability to stain nucleic acids as demonstrated here for a model nucleic acid with two kits. It was then used to monitor the removal of nucleic acids from the affinity-purified maltose binding protein and monoclonal antibody. It also worked well on staining proteins on agarose gels prepared in the vertical mode, although preparation of the vertical agarose gels required technological modifications described in this report. With the silver staining method optimized here, it should be possible in the future to analyze biological samples that may be available in limited quantity.

Keywords: Agarose; Antibody; BSA; Isoelectric point; Native gel; Silver staining.

MeSH terms

  • Animals
  • Chickens
  • Egg Proteins / chemistry*
  • Electrophoresis, Agar Gel
  • Humans
  • Nucleic Acids / chemistry*
  • Orosomucoid / chemistry*
  • SARS-CoV-2 / chemistry*
  • Silver Staining*
  • Spike Glycoprotein, Coronavirus / chemistry*

Substances

  • Egg Proteins
  • Nucleic Acids
  • Orosomucoid
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2